Navigation Links
Ludwig Institute for Cancer Research to set up its first Asian branch in Singapore
Date:11/5/2007

A memorandum of understanding (MOU) has been signed by the worlds largest international non-profit cancer research institute, the Ludwig Institute for Cancer Research (LICR), to establish a branch for translational and clinical cancer research in Singapore. This is in collaboration with three Singapore institutions, namely, the Agency for Science, Technology and Research (A*STAR), the Yong Loo Lin School of Medicine of the National University of Singapore (NUS-YLLSoM) and the Duke-NUS Graduate Medical School (Duke-NUS GMS).

The intent to establish the LICR in Singapore was announced in a speech by the city-states Minister for Health, Khaw Boon Wan, at the opening session of the American Association of Cancer Researchs (AACR) Centennial Conference held in Singapore.

LICR has 10 research branches across Australia, Europe, and North and South America. The Singapore venture would be its first in Asia.

Dr. Andrew J.G. Simpson, LICRs Scientific Director, said that the synergistic opportunities presented by Singapore were a perfect fit for LICR. The Ludwig Institute has great strength and experience in taking discoveries from investigator-initiated studies and exploring their potential clinical applications. In Singapore, the laboratory research is world-class, and there is an extraordinary clinical infrastructure ready to take the fruits of that research into clinical trials. Together, we can span the traditional divide between the laboratory and the clinic, hopefully to bring our research discoveries to human benefit. Dr. Simpson added that Singapore, with its multi-ethnic Asian population, is also advantageous for LICRs clinical studies, several of which are assessing potential treatments for cancers that particularly affect the Asian community.

LICR is well-known in the field of cancer research, producing articles of extremely high impact and conducted nearly 100 early-phase clinical trials for anti-cancer drugs, said Mr Li
'/>"/>

Contact: Sarah L. White, Ph.D.
swhite@licr.org
917-379-0398
Ludwig Institute for Cancer Research
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Palm Beach County wants to establish a Max Planck Institute in Florida
2. Midlands Consortium delighted to be chosen to host £1 billion energy institute
3. $22 million gift from Alfred Taubman launches new biomedical research institute
4. 3 Columbia University Medical Center faculty elected to Institute of Medicine
5. Stowers Institutes Xie Lab demonstrates dual intrinsic and extrinsic control of stem cell aging
6. Weizmann Institute scientists discover: A risk distribution law for evolution
7. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
8. A study by the MUHC and McGill University opens a new door to understanding cancer
9. ESF EURYI award winner aims to stop cancer cells reading their own DNA
10. Protein chatter linked to cancer activation
11. Newly created cancer stem cells could aid breast cancer research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ntists have crystallised a protein that may help g...e protein could be used by probiotic producers to ...efit to people. , "Probiotics need to interact wi...t, and if they attach to surfaces in the gut they ...rt their activity," says Dr Nathalie Juge from the...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wi...a report revealing that the last remaining populat...cantly due to the rising tide of poaching and habi... help inform Russian officials of what needs to be...d,s biggest cat. , The report was r...
(Date:11/24/2009)...s release is available in Spanish . , The p...r levels of inflammatory substances in the blood, ...s shown by a research project of the University of...scientist at the School of Pharmacy. , The proje...y in relation to the control of body weight and in...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 1Nonprofit Goes RVing to Promote Pet and Human Health 48962 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 3HPV Vaccine Acceptability Study Announces Results 48959 1HPV Vaccine Acceptability Study Announces Results 48959 2HPV Vaccine Acceptability Study Announces Results 48959 3Heart Association Warns of Surgery Risks in Obese 48956 1Heart Association Warns of Surgery Risks in Obese 48956 2
...Walter J. Lukiw, PhD, Associate Professor of Neuro...Center New Orleans, is the lead author of a paper ...on of a fragment of ribonucleic acid (RNA), once t...ng inflammation and the development of Alzheimer,s...146a-mediated inflammatory circuit in Alzheimer,s ...
...SANTA CRUZ, CA--An unusual microorganism discovere...k their understanding of how carbon and nitrogen c... by Jonathan Zehr, professor of ocean sciences at ...rized the new microbe by analyzing its genetic mat...to grow it in the laboratory. , Zehr said the ne...
...CHAPEL HILL Researchers from the University of No...ve been awarded almost $10 million to study the ma...y affect interactions between mothers and their in...dings will aid the development of new intervention... and prove valuable to others working in fields su...
Other Biology News:LSUHSC research identifies key contributor to Alzheimer's disease process 2Mysterious microbe may play important role in ocean ecology 2Mysterious microbe may play important role in ocean ecology 3UNC, Yale partner to study effects of cocaine use on mother-infant relationships 2
(Date:11/24/2009)... The New York investment bank...ASX:NEU) has agreed an AU$6.7 mil convertible note...tor. The private placement was arranged by KTA Cap...isor. , New York (PRWEB) ...stment bank KTA Capital, LLC ("KTA Capital&qu...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCal...ill be presenting at the NASDAQ OMX conference on ...45 AM US/CST. Interested parties may listen via li... http://inve s tor.sig m a a ldrich.com/ ....s file. ,, About Sigma-Aldrich: Sigma-Ald...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...ances Nfocus device development team. , , PALO AL... Nfocus Neuromedical Inc. announced today the ap...ert O,Holla to its leadership team in the role of ...,Holla brings an unmatched wealth of regulatory an... 18 of his last 30 years in the industry in the ro...
...idone role in treatment of patients with IPF - , ...t all-oral combination in HCV - , , - Strong data...in HCV - , , BRISBANE, Calif. , April 30 InterM...s from operations for the first quarter ended Marc...he first quarter of 2009 of $42.0 million, or $1.0...
...armaceuticals, Inc. (Nasdaq: IDIX ), a biopharma...lopment of drugs for the treatment of human viral ...ts for the first quarter ended March 31, 2009. At ...d marketable securities totaled $64.5 million. , ...st quarter of 2009, the company announced that it ...
Other Biology Technology:Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 3InterMune Reports First Quarter 2009 Financial Results and Business Highlights 4InterMune Reports First Quarter 2009 Financial Results and Business Highlights 5InterMune Reports First Quarter 2009 Financial Results and Business Highlights 6InterMune Reports First Quarter 2009 Financial Results and Business Highlights 7InterMune Reports First Quarter 2009 Financial Results and Business Highlights 8InterMune Reports First Quarter 2009 Financial Results and Business Highlights 9InterMune Reports First Quarter 2009 Financial Results and Business Highlights 10InterMune Reports First Quarter 2009 Financial Results and Business Highlights 11InterMune Reports First Quarter 2009 Financial Results and Business Highlights 12InterMune Reports First Quarter 2009 Financial Results and Business Highlights 13Idenix Pharmaceuticals Reports First Quarter Financial Results 2Idenix Pharmaceuticals Reports First Quarter Financial Results 3Idenix Pharmaceuticals Reports First Quarter Financial Results 4Idenix Pharmaceuticals Reports First Quarter Financial Results 5Idenix Pharmaceuticals Reports First Quarter Financial Results 6
Goat Anti-KOR-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
T7Select1-1 OrientExpress cDNA Cloning System Random Primer from Novagen
Goat Anti-VAP-1 (S-13) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
... atoms at the 3, 3', 4, and 4' positions. It is in...ntification of Prostaglandin E2 (PGE2) by GC- or L...clooxygenase products of arachidonic acid and one ...s activity influences inflammation, fertility and ...
Biology Products: